Utah allows AI prescription refills
- Utah’s Department of Commerce kept its Doctronic pilot running after the Utah Medical Licensing Board asked on April 20 to suspend AI prescription renewals. - The state says the January 6 program covers 30-, 60-, or 90-day renewals for chronic-condition drugs, with physicians reviewing every refill in phase one. - Utah launched the first state-approved AI refill pilot in January under its regulatory sandbox, testing medical waivers and oversight. (commerce.utah.gov)
Utah is still letting an artificial intelligence system help renew some prescriptions, even after the state’s medical licensing board asked officials to stop the pilot. (ksl.com) The program began January 6 through an agreement between Utah’s Office of Artificial Intelligence Policy, the Division of Professional Licensing, and health startup Doctronic. It allows 30-, 60-, and 90-day renewals for medications already prescribed for chronic conditions. (commerce.utah.gov) (ksl.com) Utah said the pilot is the first state-approved program in the country to let an AI system take part in medical decision-making on prescription renewals. The state pitched it as a way to reduce delays and medication lapses for patients managing long-term illnesses. (commerce.utah.gov) A refill sounds routine, but the board said it is still a medical judgment. In its April 20 letter, 11 of the board’s 14 members wrote that each refill can require checking side effects, drug interactions, contraindications, and whether the treatment still fits the patient. (fsmb.org) The board said it learned about the agreement only after the system was already live in Utah. It urged “immediate” suspension, saying the state had moved ahead without enough consultation from clinicians charged with protecting patients. (fsmb.org) (deseret.com) State officials declined to shut the program down. In a response dated April 21, the Department of Commerce said the pilot had already been reviewed by medical specialists and public health experts under Utah’s artificial intelligence regulatory mitigation program. (commerce.utah.gov) Utah also said critics were overstating how autonomous the system is right now. KSL reported that, in the current first phase, every renewal decision is reviewed by a licensed physician, and the pilot does not cover controlled substances or brand-new prescriptions. (ksl.com) The medications in the agreement are common long-term drugs, including blood pressure medicine, asthma inhalers, blood thinners, and contraceptives. Deseret News reported the list covers close to 200 prescriptions. (deseret.com) The legal backdrop is Utah’s 2024 law creating the Office of Artificial Intelligence Policy and its sandbox-style waiver process. That framework lets the state temporarily relax some rules, collect safety data, and report results back to lawmakers. (commerce.utah.gov) (ksl.com) For now, the fight is less about whether software can ask refill questions than about who gets to sign off on care. Utah is keeping the pilot alive while its medical board presses for a bigger role in deciding what counts as safe oversight. (fsmb.org) (commerce.utah.gov)
